In a market environment characterised by economic and political uncertainty, the PHOENIX group has strengthened its resilience and achieved growth in revenue and earnings.
The PHOENIX group has published its Sustainability Report 2023/24. In the past reporting year, the company’s particular focus has been on implementing measures towards realising its climate target for the PHOENIX group to be carbon neutral in its own business operations by 2030.
PHOENIX group completes largest acquisition in company’s history
The PHOENIX group has completed the acquisition of parts of McKesson Europe, following the clearance by competition authorities of the full scope of the transaction. The closing took place on 31 October 2022.
The company has set an official target to become CO2 -neutral in its own business operations by the year 2030. We want to avoid and reduce our emissions by at least 30 per cent (Scope 1 + 2 emissions). PHOENIX thereby underlines its commitment to creating added value for society and the environment beyond our mission in the healthcare sector.
The PHOENIX group is a partner of Team Germany at the 2024 Olympic Games
The PHOENIX group is a proud partner of Team Germany at the 2024 Olympic Games in Paris. PHOENIX exclusively supports the athletes of the German delegation in our sector and is also the exclusive supplier of medicines for the German team in pharmaceutical wholesale.
We are a successful company with a Europe-wide presence – with the down-to-earth attitude typically found in a family business. Our success is due to our highly committed employees.
